BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6142542)

  • 1. Comparative in vivo and in vitro studies of fibrinopeptide A and factor XIII subunit A levels as indicators of thrombin generation.
    Galloway MJ; McVerry BA; Mackie MJ
    Thromb Res; 1984 Jan; 33(2):229-34. PubMed ID: 6142542
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital dysfibrinogenemia.
    Rupp C; Beck EA
    Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE; Schmer G
    Thromb Res; 1985 Jan; 37(1):45-52. PubMed ID: 3983901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of fibrinopeptide A by high performance liquid chromatography and its significance.
    Mao P; Wang BM; Shen D; Wei WN
    Chin Med J (Engl); 1988 May; 101(5):353-6. PubMed ID: 3145836
    [No Abstract]   [Full Text] [Related]  

  • 10. On the location in the thrombin B chain of substrate recognition sites for fibrinopeptide release and factor XIII activation.
    Pirkle H; Theodor I; Christofferson M; Vukasin P; Miyada D
    Thromb Res; 1989 Sep; 55(6):737-46. PubMed ID: 2781534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen.
    Krarup A; Gulla KC; Gál P; Hajela K; Sim RB
    Biochim Biophys Acta; 2008 Sep; 1784(9):1294-300. PubMed ID: 18456010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation in acute myeloblastic leukemia.
    Scharf RE; Stoffels U; Schneider W
    Haematol Blood Transfus; 1990; 33():357-61. PubMed ID: 2323642
    [No Abstract]   [Full Text] [Related]  

  • 13. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Zurich I: impaired release of fibrinopeptide A.
    Hofmann V; Gati WP; Straub PW
    Thromb Haemost; 1979 Jun; 41(4):709-13. PubMed ID: 483244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated fibrinopeptide A levels in patients with clinically localised breast carcinoma.
    Auger MJ; Galloway MJ; Leinster SJ; McVerry BA; Mackie MJ
    Haemostasis; 1987; 17(6):336-9. PubMed ID: 3428719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a relationship between high fibrinogen levels and decreased thrombin activity in vivo in elderly subjects.
    Marongiu F; Mamusa AM; Dessalvi P; Mameli G; Cambuli AB; Sorano GG; Conti M; Farci P; Balestrieri A
    Haemostasis; 1989; 19(2):91-3. PubMed ID: 2731780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioimmunoassay of fibrinopeptide A-clinical applications.
    Kockum C
    Thromb Res; 1976 Feb; 8(2):225-36. PubMed ID: 1251352
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinogen Chapel Hill II: defective in reactions with thrombin, factor XIIIa and plasmin.
    Carrell N; McDonagh J
    Br J Haematol; 1982 Sep; 52(1):35-47. PubMed ID: 6126210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A excretion in urine: a marker of the cumulative thrombin activity in stable versus unstable angina patients.
    Ardissino D; Gamba MG; Merlini PA; Rolla A; Barberis P; Demicheli G; Testa S; Bruno N; Specchia G
    Am J Cardiol; 1991 Sep; 68(7):58B-63B. PubMed ID: 1892068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.